|
 |
European BioPharmaceutical Review
|
| Estimated at about $6 billion annually, the current worldwide market for vaccines centres around a list of old enemies such as tuberculosis, typhoid, cholera, tetanus, diphtheria, rabies, smallpox, yellow fever and polio. Newer vaccines have been created for chickenpox, Hepatitis B and A, influenza and pneumonia. Today, with the power of genomics, proteomics and systems biology at our fingertips, we've entered into what many believe will be a golden age for prophylactic approaches. Enter the era of 'super vaccines' -vaccines that will mitigate everything from herpes, to cancers and even AIDS. Some of them will be tailor-made to fit the individual's genetic profile. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
